Načítá se...
Anti-PD-1 Therapy-Associated Perforating Colitis
Inhibition of immune checkpoint T cell regulatory molecules by using programmed cell death protein 1 (PD-1), or its ligand (PDL-1), and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) has been increasingly used to treat advanced malignancies. The immune-related adverse effects associated with t...
Uloženo v:
| Vydáno v: | Case Rep Gastrointest Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000840/ https://ncbi.nlm.nih.gov/pubmed/29955400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/3406437 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|